NF-κB in the Nervous System
- 1Molecular Neurobiology, University of Bielefeld, Universitätsstr. 25, D-33501 Bielefeld
- 2Cell Biology, University of Bielefeld, Universitätsstr. 25, D-33501 Bielefeld
- Correspondence: barbara.kaltschmidt{at}uni-bielefeld.de
Abstract
The transcription factor NF-κB has diverse functions in the nervous system, depending on the cellular context. NF-κB is constitutively activated in glutamatergic neurons. Knockout of p65 or inhibition of neuronal NF-κB by super-repressor IκB resulted in the loss of neuroprotection and defects in learning and memory. Similarly, p50−/− mice have a lower learning ability and are sensitive to neurotoxins. Activated NF-κB can be transported retrogradely from activated synapses to the nucleus to translate short-term processes to long-term changes such as axon growth, which is important for long-term memory. In glia, NF-κB is inducible and regulates inflammatory processes that exacerbate diseases such as autoimmune encephalomyelitis, ischemia, and Alzheimer's disease. In summary, inhibition of NF-κB in glia might ameliorate disease, whereas activation in neurons might enhance memory. This review focuses on results produced by the analysis of genetic models.
Footnotes
-
Editors: Louis M. Staudt and Michael Karin
-
Additional Perspectives on NF-κB available at www.cshperspectives.org
-
↵* This review focuses on evidence from genetic mouse models. Readers interested in pharmacological approaches to NF-κB function in the nervous system should consult earlier reviews by Kaltschmidt et al. (2005), Meffert and Baltimore (2005), and Romano et al. (2006) for further information.
- Copyright © 2009 Cold Spring Harbor Laboratory Press; all rights reserved